Saudi Crown Prince and UAE President discuss regional security in phone call    First batch of Saudi doctors and volunteers lands in Damascus    Trump: US aims to catch up Saudi Arabia's sovereign wealth fund    SRMG Think hosts high-level discussion on IMF's latest GCC economic report in Riyadh    Death certificates can now be issued through Absher    GACA allows foreign operators to charter flights for domestic travelers in Saudi Arabia    PetroRent signing ceremony marks innovative collaboration between Petromin and Transregions to transform car rental and leasing services    Cristiano Ronaldo scores twice as Al Nassr thrashes Al Wasl 4-0 in AFC Champions League Elite    Al Ahli extends unbeaten run with 3-1 comeback win over Al Sadd in AFC Champions League Elite    German President visits King Salman Park Project in Riyadh    China hits back as Trump's tariffs go into effect    Guillain-Barre syndrome: India faces outbreak of creeping paralysis    Rebels declare ceasefire in DR Congo for 'humanitarian reasons'    Turmoil as Trump and Musk take aim at top US aid agency    Spain's former football boss on trial over World Cup kiss    Grammy Awards 2025: Beyoncé wins best country album    Museum Authority to open second edition of 'Art of the Kingdom' exhibition in Riyadh    Al Ittihad stages dramatic comeback to defeat Al Kholood 4-3 in thriller    Saudi composer Nasser Al-Saleh passes away at 63    Saudi drama icon Mohammed Al-Towayan passes away at 79    Bollywood star Saif Ali Khan 'out of danger' after attack at home in Mumbai    Order vs. Morality: Lessons from New York's 1977 Blackout    India puts blockbuster Pakistani film on hold    The Vikings and the Islamic world    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



US reviewing cancer risk with diabetes pill Actos
Published in Saudi Press Agency on 17 - 09 - 2010

The U.S. Food and Drug Administration is reviewing data suggesting a possible link between the widely used diabetes medication Actos and bladder cancer, according to AP.
The agency said Friday that five-year results from an ongoing study show that patients who have taken Actos for the longest period of time had a higher risk of bladder cancer. Bladder cancer was also more prevalent in patients who had taken the largest cumulative dose of the drug.
Actos manufacturer Takeda Pharmaceuticals is conducting the study, which is scheduled to run 10 years.
«The agency has not concluded that Actos increases the risk of bladder cancer,» the agency said in a statement. Patients should continue taking Actos unless told otherwise by their doctor, according to the agency statement.
Actos agreed to study the risk of bladder cancer with its drug in 2003. But a company executive said Friday the results are too preliminary to make any conclusions about the drug.
«This interim analysis raises a question, but it doesn't answer anything,» said Dr. Robert Spanheimer, vice president of medical affairs at Takeda. «We are committed to finishing the study because I think that's when you're going to get the greater understanding.»
Prescriptions for Actos have risen since 2007, when its chief competitor, Avandia, was first associated with cardiovascular problems. The FDA is considering whether to withdraw Avandia, which is marketed by British drugmaker GlaxoSmithKline. Actos and Avandia work similarly to control blood sugar and are the only drugs in their class currently on the market. A third drug called Rezulin was withdrawn in the U.S. in 1997 due to liver toxicity.
Critics of Avandia have called on the FDA to recall the drug, arguing that Actos offers the same benefits without risks of heart attack and stroke.
The FDA's review of Actos' cancer risks is preliminary, but could shape its decision on Avandia, which is expected in coming weeks.
U.S sales of Actos have risen steadily _ hitting $3.4 billion last year _ as Avandia's reputation has soured. Last year Avandia posted $520 million in sales.
Headquartered in Osaka, Japan, Takeda Pharmaceuticals Co. is the country's largest drugmaker.


Clic here to read the story from its source.